Safe and Affordable Biotech Drugs: The Need for a Generic Pathway
by
House Committee on Oversight and Government Reform
series:
Unknown
first published:
Unknown
Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
by
House Committee on Energy and Commerce
series:
Unknown
first published:
Unknown
Continuing Investigation Into the U.S. Attorneys Controversy and Related Matters (Part II)
by
House Committee on the Judiciary
series:
Unknown
first published:
Unknown
The Benefits and Challenges of Producing Liquid Fuel from Coal: The Role for Federal Research
by
House Committee on Science and Technology
series:
Unknown
first published:
Unknown